FdaApplication
ANDA 079040
Identifiers
- fda_app_no: ANDA079040
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2013-01-16 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MORPHINE SULFATE | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE;ORAL |
6 products